Adverum Biotechnologies Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswireNov 21 05:05

Express News | Adverum Biotechnologies Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

BreakingsNov 21 05:05

Truist Financial Maintains Adverum Biotechnologies(ADVM.US) With Buy Rating

Futu NewsNov 19 20:33 · Ratings

H.C. Wainwright Maintains Adverum Biotechnologies(ADVM.US) With Buy Rating, Maintains Target Price $30

Futu NewsNov 19 16:36 · Ratings

Adverum Biotechnologies Advances Ixo-vec Gene Therapy Trials

TipRanksNov 19 05:36

Buy Rating on Adverum Biotechnologies: Ixo-vec's Promising Potential in Transforming Wet AMD Treatment

TipRanksNov 19 01:35 · Ratings